Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapyW Yeo, K C Lam, B Zee, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphismsB B Y Ma, E P Hui, S C C Wong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials GroupJ Latreille, J Pater, D Johnston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors, E Lévy, P Piedbois, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcomaA M Davis, B O'Sullivan, R S Bell, et al.Breast Cancer Research and Treatment|March 11, 2008
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapyWinnie Yeo, F K F Mo, J J S Suen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site GroupK I Pritchard, A H Paterson, S Fine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trialA T C Chan, P M L Teo, R K Ngan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasmaD C T Chan, W K J Lam, E P Hui, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancerM J Piccart, K Bertelsen, G Stuart, et al.Pageof 9